Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system

por Zerp, Shuraila F., Bibi, Zainab, Verbrugge, Inge, Voest, Emile E., Verheij, Marcel
Publicado 2020

Learning health care systems: Highly needed but challenging

por Wouters, Roel H.P., van der Graaf, Rieke, Voest, Emile E., Bredenoord, Annelien L.
Publicado 2020

Patients with cancer in the era of 2019 novel coronavirus disease

por Hartemink, Koen J., van Akkooi, Alexander C.J., Houwink, Aletta P.I., Voest, Emile E.
Publicado 2020

Are health care professionals able to judge cancer patients' health care preferences correctly? A cross-sectional study

por Wessels, Hester, de Graeff, Alexander, Wynia, Klaske, de Heus, Miriam, Kruitwagen, Cas LJJ, Teunissen, Saskia CCM, Voest, Emile E
Publicado 2010

Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review

por Walraven, Maudy, Witteveen, Petronella O., Lolkema, Martijn P. J., van Hillegersberg, R., Voest, Emile E., Verheul, H. M. W.
Publicado 2010

Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation

por Dijkstra, Jelmer J., Neikes, Hannah K., Rezaeifard, Somayeh, Ma, Xuhui, Voest, Emile E., Tauriello, Daniele V. F., Vermeulen, Michiel
Publicado 2022

Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue

por Basten, Sander G, Willekers, Sven, Vermaat, Joost SP, Slaats, Gisela GG, Voest, Emile E, van Diest, Paul J, Giles, Rachel H
Publicado 2013

Cancer patients’ intentions towards receiving unsolicited genetic information obtained using next-generation sequencing

por Bijlsma, Rhodé M., Wessels, Hester, Wouters, Roel H. P., May, Anne M., Ausems, Margreet G. E. M., Voest, Emile E., Bredenoord, Annelien L.
Publicado 2017

A Comparison of Post-marketing Measures Imposed by Regulatory Agencies to Confirm the Tissue-Agnostic Approach

por Mulder, Jorn, van Stuijvenberg, Odile C., van Hennik, Paula B., Voest, Emile E., Pasmooij, Anna M. G., Stoyanova-Beninska, Violeta, de Boer, Anthonius
Publicado 2022

Fixed Dosing of Monoclonal Antibodies in Oncology

por Hendrikx, Jeroen J.M.A., Haanen, John B.A.G., Voest, Emile E., Schellens, Jan H.M., Huitema, Alwin D.R., Beijnen, Jos H.
Publicado 2017

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum

por Greijer, Astrid E., Delis-van Diemen, Pien M., Fijneman, Remond J. A., Giles, Rachel H., Voest, Emile E., van Hinsbergh, Victor W. M., Meijer, Gerrit A.
Publicado 2008

Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint

por Kleiblova, Petra, Shaltiel, Indra A., Benada, Jan, Ševčík, Jan, Pecháčková, Soňa, Pohlreich, Petr, Voest, Emile E., Dundr, Pavel, Bartek, Jiri, Kleibl, Zdenek, Medema, René H., Macurek, Libor
Publicado 2013

Identification of patient-specific CD4(+) and CD8(+) T cell neoantigens through HLA-unbiased genetic screens

por Cattaneo, Chiara M., Battaglia, Thomas, Urbanus, Jos, Moravec, Ziva, Voogd, Rhianne, de Groot, Rosa, Hartemink, Koen J., Haanen, John B. A. G., Voest, Emile E., Schumacher, Ton N., Scheper, Wouter
Publicado 2023

Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders

por Mulder, Jorn, Verjans, Robin, Verbaanderd, Ciska, Pean, Elias, Weemers, Just, Leufkens, Hubert G. M., Pignatti, Francesco, de Boer, Anthonius, Voest, Emile E., Stoyanova-Beninska, Violeta V., Pasmooij, Anna M. G.
Publicado 2021

A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus ox...

por Snoeren, Nikol, Voest, Emile E, Bergman, Andre M, Dalesio, Otilia, Verheul, Henk M, Tollenaar, Rob AEM, van der Sijp, Joost RM, Schouten, Sander B, Rinkes, Inne HM Borel, van Hillegersberg, R
Publicado 2010

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response

por Lips, Esther H., Michaut, Magali, Hoogstraat, Marlous, Mulder, Lennart, Besselink, Nicolle JM, Koudijs, Marco J., Cuppen, Edwin, Voest, Emile E., Bernards, Rene, Nederlof, Petra M., Wesseling, Jelle, Rodenhuis, Sjoerd, Wessels, Lodewyk FA
Publicado 2015

Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations

por Willemsen, Annelieke E. C. A. B., Krausz, Sarah, Ligtenberg, Marjolijn J. L., Grünberg, Katrien, Groen, Harry J. M., Voest, Emile E., Cuppen, Edwin P. J. G., van Laarhoven, Hanneke W. M., van Herpen, Carla M. L.
Publicado 2019

A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignanci...

por Cirkel, Geert A., Kerklaan, Bojana Milojkovic, Vanhoutte, Frédéric, der Aa, Annegret Van, Lorenzon, Giocondo, Namour, Florence, Pujuguet, Philippe, Darquenne, Sophie, de Vos, Filip Y. F., Snijders, Tom J., Voest, Emile E., Schellens, Jan H. M., Lolkema, Martijn P.
Publicado 2016

Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts

por Kemper, Kristel, Krijgsman, Oscar, Cornelissen-Steijger, Paulien, Shahrabi, Aida, Weeber, Fleur, Song, Ji-Ying, Kuilman, Thomas, Vis, Daniel J, Wessels, Lodewyk F, Voest, Emile E, Schumacher, Ton NM, Blank, Christian U, Adams, David J, Haanen, John B, Peeper, Daniel S
Publicado 2015

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma

por Dijkstra, Krijn K., van den Berg, José G., Weeber, Fleur, van de Haar, Joris, Velds, Arno, Kaing, Sovann, Peters, Dennis D. G. C., Eskens, Ferry A. L. M., de Groot, Derk-Jan A., Tesselaar, Margot E. T., Voest, Emile E.
Publicado 2021